Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 137-odd small cap health stocks, only 57 were in positive territory over the last fortnight; nine were flat and 68 saw their share prices fall.

Code Name Price $ (April 1) 2 week return % 1 year return % Market cap
TDL TBG DIAGNOSTICS LTD 0.27 862 592 $54,396,824
CDY CELLMID LTD 0.32 220 45 $30,910,998
RAP RESAPP HEALTH LTD 0.195 135 127 $141,575,568
LSH LIFESPOT HEALTH LTD 0.054 80 0 $4,735,655
GSS GENETIC SIGNATURES LTD 1.75 75 59 $249,457,680
OSL ONCOSIL MEDICAL LTD 0.135 47 150 $83,774,024
AGH ALTHEA GROUP HOLDINGS LTD 0.27 46 -25 $62,993,700
MEB MEDIBIO LTD 0.007 40 -59 $6,965,911
PXS PHARMAXIS LTD 0.092 37 -65 $36,324,792
OIL OPTISCAN IMAGING LTD 0.02 33 -52 $9,555,576
AVH AVITA MEDICAL LTD 0.51 32 79 $1,087,521,024
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.19 31 6 $14,893,071
CYC CYCLOPHARM LTD 1 26 -7 $78,238,400
FFC FARMAFORCE LTD 0.075 25 -21 $9,657,824
HCT HOLISTA COLLTECH LTD 0.11 25 62 $29,595,400
OSP OSPREY MEDICAL INC-CDI 0.015 25 -89 $6,476,961
PYC PYC THERAPEUTICS LTD 0.06 25 131 $175,885,680
ACW ACTINOGEN MEDICAL LTD 0.02 25 -63 $22,324,626
NTI NEUROTECH INTERNATIONAL LTD 0.005 25 -69 $698,659
GTG GENETIC TECHNOLOGIES LTD 0.005 25 -33 $20,315,670
ATH ALTERITY THERAPEUTICS LTD 0.016 23 -64 $14,390,606
PIQ PROTEOMICS INTERNATIONAL LAB 0.25 19 -17 $22,970,218
ZNO ZOONO GROUP LTD 1.825 19 1928 $298,045,696
EXL ELIXINOL GLOBAL LTD 0.295 18 -94 $40,678,764
ANP ANTISENSE THERAPEUTICS LTD 0.048 17 26 $23,461,694
ATX AMPLIA THERAPEUTICS LTD 0.058 16 -59 $3,854,865
AMT ALLEGRA ORTHOPAEDICS LTD 0.15 15 25 $14,933,858
JHL JAYEX HEALTHCARE LTD 0.015 15 -57 $2,645,445
AC8 AUSCANN GROUP HOLDINGS LTD 0.19 15 -49 $60,238,996
IDT IDT AUSTRALIA LTD 0.115 15 -23 $27,565,972
PAR PARADIGM BIOPHARMACEUTICALS 1.595 12 -13 $315,513,472
IMU IMUGENE LTD 0.02 11 5 $88,519,408
PCK PAINCHEK LTD 0.082 11 122 $84,912,840
JHC JAPARA HEALTHCARE LTD 0.5 10 -62 $133,623,664
ZLD ZELIRA THERAPEUTICS LTD 0.034 10 -36 $33,065,966
OSX OSTEOPORE LTD 0.38 9 $38,467,592
BWX BWX LTD 3 8 34 $372,749,664
MVP MEDICAL DEVELOPMENTS INTERNA 5.32 8 8 $349,030,656
SUD SUDA PHARMACEUTICALS LTD 0.049 7 -54 $6,970,466
PNV POLYNOVO LTD 1.605 6 114 $1,061,046,336
MDR MEDADVISOR LTD 0.445 6 38 $109,443,776
RSH RESPIRI LTD 0.074 6 -6 $41,163,100
TD1 TALI DIGITAL LTD 0.02 5 0 $14,986,104
RHT RESONANCE HEALTH LTD 0.105 5 14 $46,596,264
AHX APIAM ANIMAL HEALTH LTD 0.4 5 -8 $46,373,760
SDI SDI LTD 0.8 5 7 $95,092,424
OPT OPTHEA LTD 1.96 4 186 $527,549,216
BLT BENITEC BIOPHARMA LTD 0.026 4 -79 $8,353,463
NYR NYRADA INC-CDI 0.13 4 $14,219,884
PTX PRESCIENT THERAPEUTICS LTD 0.028 4 -44 $11,039,298
UBI UNIVERSAL BIOSENSORS INC-CDI 0.155 3 -23 $27,523,638
CTE CRYOSITE LTD 0.072 3 60 $3,373,889
PBP PROBIOTEC LTD 2.02 3 31 $151,053,312
MEM MEMPHASYS LTD 0.039 3 70 $29,404,982
CAN CANN GROUP LTD 0.69 1 -70 $98,271,224
NVL NATIONAL VETERINARY CARE LTD 3.67 1 104 $249,423,424
TLX TELIX PHARMACEUTICALS LTD 0.995 1 18 $252,177,616
VLS VITA LIFE SCIENCES LTD 0.63 0 -5 $34,387,044
IVX INVION LTD 0.007 0 -42 $38,504,244
ACR ACRUX LTD 0.11 0 -41 $18,532,086
ALT ANALYTICA LTD 0.002 0 -50 $7,039,225
AVE AVECHO BIOTECHNOLOGY LTD 0.002 0 -43 $3,154,915
BPHDC BPH ENERGY LTD 0.006 0 -40 $2,004,878
M7T MACH7 TECHNOLOGIES LTD 0.52 0 181 $95,071,152
RGS REGENEUS LTD 0.07 0 -35 $19,447,750
ESE ESENSE-LAB LTD-CDI 0.005 0 -78 $950,385
ADO ANTEOTECH LTD 0.016 0 1 $26,305,294
FTT FACTOR THERAPEUTICS LTD 0.0025 0 -29 $2,607,089
MMJ MMJ GROUP HOLDINGS LTD 0.076 0 -68 $17,054,322
CPH CRESO PHARMA LTD 0.059 -2 -84 $12,260,753
OCC ORTHOCELL LTD 0.25 -2 79 $46,174,680
LBT LBT INNOVATIONS LTD 0.1075 -2 41 $25,320,526
THC THC GLOBAL GROUP LTD 0.215 -2 -62 $30,265,452
IHL IMPRESSION HEALTHCARE LTD 0.036 -3 50 $25,826,974
PAA PHARMAUST LTD 0.068 -3 79 $20,537,432
DXB DIMERIX LTD 0.14 -3 63 $25,413,740
IMC IMMURON LTD 0.08 -4 -63 $14,177,472
ALC ALCIDION GROUP LTD 0.13 -4 100 $128,790,224
UCM USCOM LTD 0.25 -4 47 $37,414,776
GMV G MEDICAL INNOVATION HOLDING 0.045 -4 -84 $19,205,964
S66 STAR COMBO PHARMA LTD 0.45 -4 -22 $38,941,472
CGS COGSTATE LTD 0.33 -4 45 $56,114,904
BD1 BARD1 LIFE SCIENCES LTD 0.021 -5 32 $28,710,886
SVA SIMAVITA LTD-CDI 0.017 -6 0 $8,712,978
RAC RACE ONCOLOGY LTD 0.25 -6 191 $28,898,116
EHH EAGLE HEALTH HOLDINGS LTD 0.14 -6 -50 $51,606,324
PSQ PACIFIC SMILES GROUP LTD 0.995 -6 -11 $151,233,424
ONT 1300 SMILES LTD 5.1 -7 -13 $120,759,760
MX1 MICRO-X LTD 0.135 -7 -50 $33,752,760
VHT VOLPARA HEALTH TECHNOLOGIES 1.07 -7 -23 $233,773,568
PAB PATRYS LTD 0.013 -7 -46 $13,943,674
NC6 NANOLLOSE LTD 0.037 -8 -45 $2,775,000
RCE RECCE PHARMACEUTICALS LTD 0.26 -9 30 $35,248,664
CYP CYNATA THERAPEUTICS LTD 0.69 -9 -44 $71,082,528
BIT BIOTRON LTD 0.088 -9 17 $61,770,080
MDC MEDLAB CLINICAL LTD 0.19 -10 -49 $44,312,144
SCU STEMCELL UNITED LTD 0.009 -10 -55 $5,774,476
RHY RHYTHM BIOSCIENCES LTD 0.052 -10 -68 $5,239,000
ELX ELLEX MEDICAL LASERS LTD 0.52 -10 -15 $74,672,592
CDX CARDIEX LTD 0.016 -11 -58 $12,051,349
VBS VECTUS BIOSYSTEMS LTD 0.52 -11 16 $12,300,504
1AD ADALTA LTD 0.055 -11 -76 $9,017,009
ICS ICSGLOBAL LTD 1.48 -12 69 $15,693,948
SDX SIENNA CANCER DIAGNOSTICS LT 0.022 -12 -67 $8,692,922
BNO BIONOMICS LTD 0.033 -13 -81 $17,974,634
AZV AZURE HEALTHCARE LTD 0.06 -14 -4 $17,051,338
SIL SMILES INCLUSIVE LTD 0.035 -15 -87 $5,059,651
PGC PARAGON CARE LTD 0.125 -17 -72 $42,235,660
CMP COMPUMEDICS LTD 0.33 -18 -29 $58,463,772
NEU NEUREN PHARMACEUTICALS LTD 0.99 -18 -15 $102,138,320
NOX NOXOPHARM LTD 0.14 -18 -65 $21,320,060
NXS NEXT SCIENCE LTD 1.285 -19 $231,586,368
BXN BIOXYNE LTD 0.008 -20 -62 $5,121,163
1ST 1ST GROUP LTD 0.024 -20 -49 $10,190,806
ONE ONEVIEW HEALTHCARE PLC-CDI 0.04 -20 -89 $6,928,460
ANR ANATARA LIFESCIENCES LTD 0.16 -20 -67 $7,976,989
PAL PALLA PHARMA LTD 0.55 -20 -51 $69,271,384
CP1 CANNPAL ANIMAL THERAPEUTICS 0.082 -22 -32 $7,636,250
CAJ CAPITOL HEALTH LTD 0.175 -22 -17 $135,677,632
GLH GLOBAL HEALTH LTD 0.105 -22 -30 $4,420,324
IBX IMAGION BIOSYSTEMS LTD 0.012 -24 -49 $6,339,899
KZA KAZIA THERAPEUTICS LTD 0.4 -27 -13 $28,866,670
OVN OVENTUS MEDICAL LTD 0.245 -27 -8 $31,979,780
SKN SKIN ELEMENTS LTD 0.016 -27 -39 $5,082,290
ADR ADHERIUM LTD 0.013 -28 -54 $6,461,574
LCT LIVING CELL TECHNOLOGIES LTD 0.009 -31 -76 $5,142,969
MVF MONASH IVF GROUP LTD 0.455 -31 -55 $107,282,576
IPD IMPEDIMED LTD 0.04 -33 -81 $20,441,972
RNO RHINOMED LTD 0.073 -34 -63 $12,352,039
MXC MGC PHARMACEUTICALS LTD 0.017 -35 -53 $24,559,662
HLA HEALTHIA LTD 0.595 -35 -37 $37,505,620
SOM SOMNOMED LTD 1.12 -35 -25 $76,543,568
APH AUSTRALIAN PRIMARY HEMP LTD 0.05 -38 -77 $3,487,757
DVL DORSAVI LTD 0.01 -41 -76 $2,314,275
VTI VISIONEERING TECH-CDI 0.012 -57 -83 $5,589,622
IMM IMMUTEP LTD 0.13 -59 -60 $50,912,020
BOT BOTANIX PHARMACEUTICALS LTD 0.023 -71 -80 $22,372,056

The last edition of Check Up saw just nine stocks in the black, in our list of 137.

Two weeks and several market ups and downs later, biotechs and a small handful of health companies are, in the main, back in the black.

Biotech Daily’s BDI-40 index was up 23 per cent in March, mainly thanks to the three large caps CSL (ASX:CSL), Cochlear (ASX:COH), and ResMed (ASX:RMD) which make up slightly more than half of that index.

In that same period the ASX 200 dropped by 21 per cent.

The remainder of that index is largely shared with companies on the list of health and biotechnology stocks collated by Stockhead.

The top five movers over the last fortnight were all COVID-19-related: two had symptom monitoring devices and three were making coronavirus testing kits (although there appears to be come confusion among those about what they’re testing for — antigens, which tell you if you’ve got the virus now, or antibodies which tell you if you’ve had it in the past).

Then at #6, we had Oncosil (ASX:OSL).

Yesterday it came out with big, non-COVID-19 news, that it has approval to sell its pancreatic cancer treatment device in Europe.

This came exactly a fortnight after it got Breakthrough Device designation from the US Federal Drug Administration (FDA), a program intended to accelerate the FDA review and approval of designated devices that may provide more effective treatment of life-threatening or irreversibly debilitating diseases.

The device is an implant containing microparticles of phosphorus-32, a pure beta-emitter radioisotope, implanted directly into a patient’s pancreatic tumour.

Few survive pancreatic cancer, a form that is typically diagnosed too late to treat. Just over 9 per cent of people live more than five years after being diagnosed with the disease, and it has claimed people such as Steve Jobs and Patrick Swazye.

Pot stock Althea (ASX:AGH) was up on news this week that notwithstanding the COVID-19 pandemic, March was on track to be its highest ever revenue month.

It said it had signed up 617 new patients in Australia in February and total patient numbers hit 5000.

The company says it is shipping “more Althea product to the UK than ever before”, but doesn’t say how large or small that quantity is.

And mental health technology company Medibio (ASX:MEB) signed an MOU with NYSE-listed DXC Technology to set up a framework that identifies opportunities for Medibio’s corporate well-being product ilumen, which screens people for symptoms of depression, anxiety, and stress.

Medibio and DXC are trying to find ways to work together to sell lumen around the world. In particular, they plan to use each other’s sales and distribution channels to sell to mining, oil and gas clients with fly-in fly-out (FIFO) workforces who, studies have shown, are more likely to suffer from anxiety and depression than office-based workers.